A trial of sacituzumab govitecan for urothelial cancer (urinary tract cancer) that has spread (TROPHY U-01)

This trial is looking at a new drug called sacituzumab govitecan on its own or in combination with other cancer treatments for urinary tract cancer.

It is for people who have urinary tract cancer that:

• has grown into nearby tissues and you can’t have surgery to remove it or

• has spread to another part of the body (metastatic cancer)

The lining of the urinary tract is called the urothelium, so cancer of the urinary tract can also be called urothelial cancer.